Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
Michelle I HigginsDylan J MartiniDattatraya H PatilReza NabavizadehSean SteeleMilton WilliamsShreyas S JoshiVikram M NarayanAarti SekharSarah P PsutkaKenneth OganMehmet Asim BilenViraj A MasterPublished in: Cancer (2021)
Kidney cancer is a disease with a wide variety of outcomes. Among patients undergoing surgical removal of the kidney for cancer that has not spread beyond the kidney, many are cured, but some experience recurrence. Physicians are seeking ways to better predict who is at risk for recurrence or death from kidney cancer. This study has evaluated body composition and markers of inflammation before surgery to predict the risk of recurrence or death after surgery. Specifically, low muscle mass and an elevated inflammation score (the modified Glasgow Prognostic Score) have been associated with an increased likelihood of recurrence of kidney cancer and death.
Keyphrases
- papillary thyroid
- body composition
- squamous cell
- patients undergoing
- oxidative stress
- renal cell carcinoma
- primary care
- free survival
- mental health
- squamous cell carcinoma
- lymph node metastasis
- coronary artery disease
- young adults
- acute coronary syndrome
- insulin resistance
- high intensity
- percutaneous coronary intervention